Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101231
Status:
TERMINATED
Last Update Posted:
2013-06-04
First Post:
2005-01-07
Brief Title:
Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Relapsing Chronic Myelogenous Leukemia |
| Adult Acute Basophilic Leukemia |
| Adult Acute Eosinophilic Leukemia |
| Adult Acute Megakaryoblastic Leukemia M7 |
| Adult Acute Minimally Differentiated Myeloid Leukemia M0 |
| Adult Acute Monoblastic Leukemia M5a |
| Adult Acute Monocytic Leukemia M5b |
| Adult Acute Myeloblastic Leukemia With Maturation M2 |
| Adult Acute Myeloblastic Leukemia Without Maturation M1 |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Adult Acute Myelomonocytic Leukemia M4 |
| Adult Erythroleukemia M6a |
| Adult Pure Erythroid Leukemia M6b |
| Blastic Phase Chronic Myelogenous Leukemia |
| Recurrent Adult Acute Lymphoblastic Leukemia |
| Recurrent Adult Acute Myeloid Leukemia |
Keywords: